230 related articles for article (PubMed ID: 31896942)
21. Proficiency testing for bacterial whole genome sequencing: an end-user survey of current capabilities, requirements and priorities.
Moran-Gilad J; Sintchenko V; Pedersen SK; Wolfgang WJ; Pettengill J; Strain E; Hendriksen RS;
BMC Infect Dis; 2015 Apr; 15():174. PubMed ID: 25887164
[TBL] [Abstract][Full Text] [Related]
22. Reference Samples to Compare Next-Generation Sequencing Test Performance for Oncology Therapeutics and Diagnostics.
Pfeifer JD; Loberg R; Lofton-Day C; Zehnbauer BA
Am J Clin Pathol; 2022 Apr; 157(4):628-638. PubMed ID: 34871357
[TBL] [Abstract][Full Text] [Related]
23. In Silico Proficiency Testing for Clinical Next-Generation Sequencing.
Duncavage EJ; Abel HJ; Pfeifer JD
J Mol Diagn; 2017 Jan; 19(1):35-42. PubMed ID: 27863262
[TBL] [Abstract][Full Text] [Related]
24. Targeted, high-depth, next-generation sequencing of cancer genes in formalin-fixed, paraffin-embedded and fine-needle aspiration tumor specimens.
Hadd AG; Houghton J; Choudhary A; Sah S; Chen L; Marko AC; Sanford T; Buddavarapu K; Krosting J; Garmire L; Wylie D; Shinde R; Beaudenon S; Alexander EK; Mambo E; Adai AT; Latham GJ
J Mol Diagn; 2013 Mar; 15(2):234-47. PubMed ID: 23321017
[TBL] [Abstract][Full Text] [Related]
25. Performance Comparison of Different Analytic Methods in Proficiency Testing for Mutations in the
Moncur JT; Bartley AN; Bridge JA; Kamel-Reid S; Lazar AJ; Lindeman NI; Long TA; Merker JD; Rai AJ; Rimm DL; Rothberg PG; Vasalos P; Kim AS
Arch Pathol Lab Med; 2019 Oct; 143(10):1203-1211. PubMed ID: 30969158
[TBL] [Abstract][Full Text] [Related]
26. Use of the Ion AmpliSeq Cancer Hotspot Panel in clinical molecular pathology laboratories for analysis of solid tumours: With emphasis on validation with relevant single molecular pathology tests and the Oncomine Focus Assay.
Lee A; Lee SH; Jung CK; Park G; Lee KY; Choi HJ; Min KO; Kim TJ; Lee EJ; Lee YS
Pathol Res Pract; 2018 May; 214(5):713-719. PubMed ID: 29615338
[TBL] [Abstract][Full Text] [Related]
27. Implementation, Evolution, and Laboratory Performance of Methods-Based Proficiency Testing for Next-Generation Sequencing Detection of Germline Sequence Variants.
Tsuchiya KD; Funke B; Hegde M; Santani A; Souers RJ; Szelinger S; Halley J; Zhao Q; Mot N; Roy A; Smith VL; Zhang BM; Voelkerding K; Moyer AM
Arch Pathol Lab Med; 2024 Jul; 148(7):775-783. PubMed ID: 37852169
[TBL] [Abstract][Full Text] [Related]
28. Next-Generation Sequencing Somatic and Germline Assay Troubleshooting Guide Derived From Proficiency Testing Data.
Nardi V; Tsuchiya KD; Kim AS; Bean LJH; Halley JG; Long TA; Szelinger S; Vasalos P; Thorson JA; Moyer AM; Moncur JT
Arch Pathol Lab Med; 2022 Apr; 146(4):451-461. PubMed ID: 34424952
[TBL] [Abstract][Full Text] [Related]
29. A Window Into Clinical Next-Generation Sequencing-Based Oncology Testing Practices.
Nagarajan R; Bartley AN; Bridge JA; Jennings LJ; Kamel-Reid S; Kim A; Lazar AJ; Lindeman NI; Moncur J; Rai AJ; Routbort MJ; Vasalos P; Merker JD
Arch Pathol Lab Med; 2017 Dec; 141(12):1679-1685. PubMed ID: 29028368
[TBL] [Abstract][Full Text] [Related]
30. External Quality Assurance of Current Technology for the Testing of Cancer-Associated Circulating Free DNA Variants.
Chai SY; Peng R; Zhang R; Zhou L; Pillay N; Tay KH; Badrick T; Li J; Horan MP
Pathol Oncol Res; 2020 Jul; 26(3):1595-1603. PubMed ID: 31487000
[TBL] [Abstract][Full Text] [Related]
31. Improvement in the quality of molecular analysis of EGFR in non-small-cell lung cancer detected by three rounds of external quality assessment.
Deans ZC; Bilbe N; O'Sullivan B; Lazarou LP; de Castro DG; Parry S; Dodson A; Taniere P; Clark C; Butler R
J Clin Pathol; 2013 Apr; 66(4):319-25. PubMed ID: 23378269
[TBL] [Abstract][Full Text] [Related]
32. Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies.
Houghton J; Hadd AG; Zeigler R; Haynes BC; Latham GJ
J Vis Exp; 2016 Apr; (110):e53836. PubMed ID: 27166994
[TBL] [Abstract][Full Text] [Related]
33. Implementation of an ISO15189 accredited next-generation sequencing service with the fully automated Ion Torrent Genexus: the experience of a clinical diagnostic laboratory.
Werner R; Connolly A; Bennett M; Hand CK; Burke L
J Clin Pathol; 2024 Mar; 77(4):278-283. PubMed ID: 36522176
[TBL] [Abstract][Full Text] [Related]
34. A machine learning model to determine the accuracy of variant calls in capture-based next generation sequencing.
van den Akker J; Mishne G; Zimmer AD; Zhou AY
BMC Genomics; 2018 Apr; 19(1):263. PubMed ID: 29665779
[TBL] [Abstract][Full Text] [Related]
35. Four-Year Laboratory Performance of the First College of American Pathologists In Silico Next-Generation Sequencing Bioinformatics Proficiency Testing Surveys.
Furtado LV; Souers RJ; Vasalos P; Halley JG; Aisner DL; Nagarajan R; Voelkerding KV; Merker JD; Konnick EQ
Arch Pathol Lab Med; 2023 Feb; 147(2):137-142. PubMed ID: 35671151
[TBL] [Abstract][Full Text] [Related]
36. Comprehensive evaluation and validation of targeted next-generation sequencing performance in two clinical laboratories.
Mendez P; Dang J; Kim JW; Lee S; Yoon JH; Kim T; Sailey CJ; Jablons DM; Kim IJ
Int J Oncol; 2016 Jul; 49(1):235-42. PubMed ID: 27121194
[TBL] [Abstract][Full Text] [Related]
37. One byte at a time: evidencing the quality of clinical service next-generation sequencing for germline and somatic variants.
Gutowska-Ding MW; Deans ZC; Roos C; Matilainen J; Khawaja F; Brügger K; Ahn JW; Boustred C; Patton SJ
Eur J Hum Genet; 2020 Feb; 28(2):202-212. PubMed ID: 31570784
[TBL] [Abstract][Full Text] [Related]
38. Observations from a national sample exchange program for molecular haematology testing.
Gould C; McBean M; Thompson E; Lickiss J; Tiong IS; Westerman D; Blombery P
Pathology; 2024 Jun; 56(4):540-547. PubMed ID: 38413254
[TBL] [Abstract][Full Text] [Related]
39. Validation of a next-generation-sequencing cancer panel for use in the clinical laboratory.
Simen BB; Yin L; Goswami CP; Davis KO; Bajaj R; Gong JZ; Peiper SC; Johnson ES; Wang ZX
Arch Pathol Lab Med; 2015 Apr; 139(4):508-17. PubMed ID: 25356985
[TBL] [Abstract][Full Text] [Related]
40. Analysis of a large cohort of non-small cell lung cancers submitted for somatic variant analysis demonstrates that targeted next-generation sequencing is fit for purpose as a molecular diagnostic assay in routine practice.
Moore DA; Balbi K; Ingham A; Arkenau HT; Bennett P
J Clin Pathol; 2018 Nov; 71(11):1001-1006. PubMed ID: 30054375
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
